Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2025-12-25 @ 1:45 AM
NCT ID:
NCT00640094
Eligibility Criteria:
Inclusion Criteria:
1. Aged between 18 and 75 years.
2. Having experienced continuous ischemic (cardiac) symptoms for at least 20 minutes.
3. Having onset of symptoms of qualifying acute myocardial infarction within the past 6 hours and be expected to undergo primary angioplasty.
4. Having an electrocardiogram indicative of an acute ST segment -elevation myocardial infarction showing:
\> 2 mm ST segment elevation in 2 anterior or lateral leads; or \> 2 mm ST segment elevation in 2 inferior leads coupled with ST depression in 2 contiguous anterior leads for a total ST deviation of \> 8 mm; or new left bundle branch block with at least 1 mm concordant ST elevation.
5. Being willing to provide informed consent (informed consent may be provided by a legally authorized representative if the patient is not able to provide it according to local ethical standards).
6. Being willing and able to be followed for at least 3 months for evaluation.
Exclusion Criteria:
A patient will be ineligible for study entry if he/she meets any of the following criteria:
1. prehospital thrombolysis,
2. Killip class IV on admission,
3. known history of prior myocardial infarction,
4. known history of renal failure,
5. history of severe allergic reaction,
6. history of autoimmune diseases,
7. pregnancy,
8. severe concurrent illness with reduced short-term prognosis,
9. inability to give informed consent and
10. participation in another study within the past 30 days.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT00640094
Study Brief:
Protocol Section:
NCT00640094